A Registry Study on HIV-related Lymphoma

NCT05231135 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-04-06

No results posted yet for this study

Summary

Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.

Conditions

  • AIDS Related Lymphoma
  • HIV Related Lymphoma

Sponsors & Collaborators

  • Rotkreuzklinikum München gGmbH

    lead OTHER

Principal Investigators

  • Marcus Hentrich, MD · Rotkreuzklinikum München

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-25
Primary Completion
2024-08-31
Completion
2029-08-31

Countries

  • Germany
  • Netherlands
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05231135 on ClinicalTrials.gov